Long-Term Opportunity in Biotech
While the coronavirus outbreak has propelled biotech to the forefront, this is a sector Bailard has been watching for years.
top of page
The Pace and Price of Innovation
David H. Smith, CFA, Senior Vice President, Domestic Equities Matt Johnson, Vice President, Healthcare Investments at Bailard December...
bottom of page